The basic principle in the Biocidal Products Regulation ((EU) No 528/2012 (BPR)) is that a biocidal product (BP) must be authorised before it can be made available on the market or used in the European Union (EU)/ European Economic Area (EEA).
This takes place in two consecutive steps. As the first step, the active substance is evaluated and, provided the criteria are fulfilled, is then approved in a specified product-type (PT). The second step is the authorisation of each BP consisting of, containing or generating the approved active substance(s).
This document concerns the first step, approval of active substances.
October 2016
Collegati
ID 20661 | 27.10.2023
ECHA’s third report on the operation of the Prior Informed Consent (PIC) Regulation shows that the ove...
Decreto 2 aprile 2019
Entrata in vigore dei testi, nelle lingue inglese e francese, pubblicati nel Supplemento 9.7 della Farmacopea Europea ...
Linee guida per il controllo ufficiale sui materiali e oggetti destinati a venire a contatto con gli alimenti (MOCA/FCM).
Ed. 2011
Ed. 2012
Ed. 2015
Ed. 2018
Lo scopo del presente docum...
Testata editoriale iscritta al n. 22/2024 del registro periodici della cancelleria del Tribunale di Perugia in data 19.11.2024
